Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 29:13:1013900.
doi: 10.3389/fimmu.2022.1013900. eCollection 2022.

Oral manifestations serve as potential signs of ulcerative colitis: A review

Affiliations
Review

Oral manifestations serve as potential signs of ulcerative colitis: A review

Chunyu Li et al. Front Immunol. .

Abstract

As an immune dysregulation-related disease, although ulcerative colitis (UC) primarily affects the intestinal tract, extraintestinal manifestations of the disease are evident, particularly in the oral cavity. Herein, we have reviewed the various oral presentations, potential pathogenesis, and treatment of oral lesions related to UC. The oral manifestations of UC include specific and nonspecific manifestations, with the former including pyostomatitis vegetans and the latter encompassing recurrent aphthous ulcers, atrophic glossitis, burning mouth syndrome, angular cheilitis, dry mouth, taste change, halitosis, and periodontitis. Although the aetiology of UC has not been fully determined, the factors leading to its development include immune system dysregulation, dysbiosis, and malnutrition. The principle of treating oral lesions in UC is to relieve pain, accelerate the healing of lesions, and prevent secondary infection, and the primary procedure is to control intestinal diseases. Systemic corticosteroids are the preferred treatment options, besides, topical and systemic administration combined with dietary guidance can also be applied. Oral manifestations of UC might accompany or precede the diagnosis of UC, albeit with the absence of intestinal symptoms; therefore, oral lesions, especially pyostomatitis vegetans, recurrent aphthous ulcer and periodontitis, could be used as good mucocutaneous signs to judge the occurrence and severity of UC, thus facilitating the early diagnosis and treatment of UC and avoiding severe consequences, such as colon cancer.

Keywords: immune dysfunction; inflammatory bowel disease; oral manifestation; pyostomatitis vegetans; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Typical clinical features of one patient with PSV in our clinic. Widespread yellow or white pustular lesions as well as its secondary ulcers were observed on the palate (A), the labial gingivae (B), the anterior floor of mouth (C), and the lower lip (D) of the patient. PSV, Pyostomatitis vegetans.
Figure 2
Figure 2
Pathogenesis of the oral manifestations associated with UC. UC, Ulcerative colitis; MALT, mucosa-associated lymphatic tissue; MCP, monocyte chemoattractant protein; IL, interleukin; MMP-8, matrix-metalloproteinase 8; TNF, tumour necrosis factor; PSV, Pyostomatitis vegetans.

Similar articles

Cited by

References

    1. Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol (2016) 22:895–905. doi: 10.3748/wjg.v22.i3.895 - DOI - PMC - PubMed
    1. Ramos GP, Papadakis KA. Mechanisms of disease: Inflammatory bowel diseases. Mayo Clinic Proc (2019) 94:155–65. doi: 10.1016/j.mayocp.2018.09.013 - DOI - PMC - PubMed
    1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 448:427–34. doi: 10.1038/nature06005 - DOI - PubMed
    1. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F. Ulcerative colitis. Lancet (London England) (2017) 389:1756–70. doi: 10.1016/S0140-6736(16)32126-2 - DOI - PMC - PubMed
    1. Mavroudis G, Magnusson MK, Isaksson S, Sundin J, Simrén M, Öhman L, et al. . Mucosal and systemic immune profiles differ during early and late phases of the disease in patients with active ulcerative colitis. J Crohn's Colitis (2019) 13:1450–8. doi: 10.1093/ecco-jcc/jjz072 - DOI - PubMed

Publication types

Substances